Search
for
Sort by
Research 271–300 of 489
- 056 IKZF1 and IKAROS overexpression contributes to the pathogenesis of alopecia areata
- Updates In The Pathogenesis Of Alopecia Areata
- 080 Mouse models of alopecia areata: C3H/HeJ mice versus the humanized AA mouse model
- 원형탈모증(alopecia areata)의 최신 이해와 치료
- 319 Novel Circulating Natural Killer Cell Subset as Biomarkers in Alopecia Areata Progression
- ULBP3: a marker for alopecia areata incognita
- 649 Gut microbiota plays a role in the development of alopecia areata
- 516 Possible role of ILC1 in the pathogenesis of alopecia areata (AA)
- Getting to the root of hair loss in alopecia
- Generation of autoreactive CD8 T cell in a mouse model of alopecia areata
- Innate lymphoid cells type 1 may be new, non-antigen-specific player in the pathogenesis of alopecia areata
- Inhibiting Janus kinases to treat alopecia areata
- Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Butyrophilin-like 2 (BTNL2) to the Rescue: controlling autoaggressive dermal gamma delta (GD) T lymphocytes in human hair follicles (HFs) 3747
- Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
- 431 Innate lymphoid cells type 1 may be new, non-antigen-specific player in the pathogenesis of alopecia areata
- Pharmacological Inhibition of Stearoyl CoA Desaturase in the Skin Induces Atrophy of the Sebaceous Glands
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Alopecia Areata
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Evidence for the off-label use of tofacitinib in alopecia areata
- Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata
- Alopecia Areata and Vitamin D3 Deficiency: The Potential of Calcipotriol as a Treatment
- Treatment of alopecia areata with JAK inhibitors: a review of the literature